RenovoRx, Inc.
RNXT
$0.85
-$0.02-2.77%
NASDAQ
Corporate Info
Website
Phone Number
650 284 4433
Address
2570 West El Camino Real
Suite 320
Mountain View, CA 94040
Suite 320
Mountain View, CA 94040
Country
United States
Year Founded
2009
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.